Hainan Shuangcheng Pharmaceuticals Co., Ltd. (HNSP) is a publicly-traded Chinese pharmaceutical company founded in 2000, engaged in R&D, manufacturing, and sales of pharmaceutical products with a focus on peptide APIs and injectable formulations. The company offers CDMO/contract manufacturing services representing 20-35% of revenue, and has FDA-registered facilities with multiple FDA inspection history. It operates manufacturing sites in Haikou and has invested in a Ningbo facility.
peptide API manufacturing, injectable formulations, contract manufacturing, sterile processing
1 site worldwide
No reviews available yet.
No documents available.